Korean J Obstet Gynecol Search

CLOSE


Korean Journal of Obstetrics & Gynecology 2002;45(7):1236-1240.
Published online July 1, 2002.
A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient.
Jun Mo Ahn, Shin Ah Kim, Seok Min Lee, Yun Hee Lee, Dae Won Kim, Jib Kwang Chung, Seong Uk Kim, Hwan Sung Joe, Im Soon Lee, Dong Won Kim
1Department of Obstetrics & Gynecology, College of Medicine, Soonchunhyung University, Seoul, Korea.
2Department of Anatomic Pathology, College of Medicine, Soonchunhyung University, Seoul, Korea.
Abstract
Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.
Key Words: Tamoxifen, Carcinosarcoma


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
POLICY
FOR CONTRIBUTORS
Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea
Tel: +82-2-3445-2382    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2020 by Korean Society of Obstetrics and Gynecology. All rights reserved.

Developed in M2community

Close layer
prev next